公开(公告)号：US11498963B2

公开(公告)日：2022-11-15

申请号：US16678049

申请日：2019-11-08

Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

Inventor： Chengcheng Zhang ,  Mi Deng ,  Wei Xiong ,  Zhiqiang An ,  Ningyan Zhang ,  Xun Gui ,  Junke Zheng

IPC: A61K39/00 ,  C07K16/28 ,  G01N33/574 ,  C12N15/113 ,  A61P35/02 ,  A61K39/395 ,  A61K45/06 ,  C07K16/30

Abstract: The present disclosure is directed to antibodies binding to LILRBs and methods of detecting and treating cancer therewith.

公开(公告)号：US11013704B2

公开(公告)日：2021-05-25

申请号：US15312790

申请日：2015-05-12

Applicant: The Board of Regents of the University of Texas System

Inventor： Chengcheng Zhang ,  Yi Liu ,  Junke Zheng ,  Mi Deng ,  Chuo Chen ,  Jiawei Liu

IPC: A61K31/194 ,  A61K31/197 ,  C12N5/078 ,  C12N5/0789 ,  A61K31/155 ,  A61K31/20 ,  C07C279/14 ,  A61K45/06 ,  A61K35/65 ,  A61K38/01

Abstract: The present disclosure relates to methods of using a compound to induce regeneration of hematopoietic stem cells or increase the recovery of red blood cells. In some aspects, the present methods can be used to with or in place of erythropoietin in patients to mitigate the side effects of erythropoietin.